Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study

Francesco Autore, Luca Laurenti, Gianluigi Reda et al.|Hematological Oncology|2023

Cited by 2